Frank Takkinen
Stock Analyst at Lake Street
(0.29)
# 4,353
Out of 4,592 analysts
659
Total ratings
38.4%
Success rate
-3.1%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDXG MiMedx Group | Reiterated: Buy | $5 → $7 | $4.13 | +69.49% | 9 | Jul 30, 2026 | |
| AXGN Axogen | Reiterated: Buy | $50 → $55 | $42.21 | +30.30% | 14 | Jul 30, 2026 | |
| SMTI Sanara MedTech | Downgraded: Hold | $32 → $35 | $33.86 | +3.37% | 3 | Jul 30, 2026 | |
| LUNG Pulmonx | Reiterated: Buy | $4 | $1.63 | +145.40% | 18 | Jul 30, 2026 | |
| BBNX Beta Bionics | Reiterated: Buy | $20 | $12.83 | +55.88% | 13 | Jul 30, 2026 | |
| NPCE NeuroPace | Reiterated: Buy | $20 | $12.89 | +55.16% | 49 | Jul 29, 2026 | |
| ELUT Elutia | Reiterated: Buy | $5 | $0.8568 | +483.57% | 31 | Jul 17, 2026 | |
| RCEL AVITA Medical | Reiterated: Buy | $6 | $4.40 | +36.36% | 12 | Jul 16, 2026 | |
| ANGO AngioDynamics | Maintained: Buy | $24 | $14.79 | +62.27% | 5 | Jul 14, 2026 | |
| CVRX CVRx, Inc. | Reiterated: Buy | $14 | $5.18 | +170.53% | 45 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.5 | $0.9358 | +167.15% | 19 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $26.83 | +67.72% | 36 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $4.54 | +76.21% | 21 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $14.94 | +100.80% | 49 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.65 | +515.38% | 15 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $10.50 | +119.05% | 5 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.3783 | +957.36% | 7 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $14.75 | +42.37% | 1 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.26 | +217.46% | 38 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $0.7299 | +174.01% | 37 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $5.01 | +99.60% | 17 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $19.50 | +156.41% | 4 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $4.11 | +94.65% | 34 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $5.26 | +128.14% | 26 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $135 | $101.32 | +33.24% | 12 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $120 | $90.86 | +32.07% | 19 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $15 | $7.84 | +91.33% | 9 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.6706 | +794.72% | 17 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 | $50.21 | +198.75% | 28 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.5 | $4.11 | n/a | 18 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $6.12 | n/a | 11 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $4.95 | n/a | 6 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22.43 → $19.63 | $10.38 | n/a | 9 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 → $40 | $0.000001 | n/a | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $12 | $0.11 | n/a | 3 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1 | $2.91 | n/a | 4 | Sep 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $10 | $4.05 | n/a | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5.61 | $0.30 | n/a | 1 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 → $10 | $0.0003 | n/a | 3 | Mar 31, 2022 |
MiMedx Group
Jul 30, 2026
Reiterated: Buy
Price Target: $5 → $7
Current: $4.13
Upside: +69.49%
Axogen
Jul 30, 2026
Reiterated: Buy
Price Target: $50 → $55
Current: $42.21
Upside: +30.30%
Sanara MedTech
Jul 30, 2026
Downgraded: Hold
Price Target: $32 → $35
Current: $33.86
Upside: +3.37%
Pulmonx
Jul 30, 2026
Reiterated: Buy
Price Target: $4
Current: $1.63
Upside: +145.40%
Beta Bionics
Jul 30, 2026
Reiterated: Buy
Price Target: $20
Current: $12.83
Upside: +55.88%
NeuroPace
Jul 29, 2026
Reiterated: Buy
Price Target: $20
Current: $12.89
Upside: +55.16%
Elutia
Jul 17, 2026
Reiterated: Buy
Price Target: $5
Current: $0.8568
Upside: +483.57%
AVITA Medical
Jul 16, 2026
Reiterated: Buy
Price Target: $6
Current: $4.40
Upside: +36.36%
AngioDynamics
Jul 14, 2026
Maintained: Buy
Price Target: $24
Current: $14.79
Upside: +62.27%
CVRx, Inc.
Jul 6, 2026
Reiterated: Buy
Price Target: $14
Current: $5.18
Upside: +170.53%
Jul 1, 2026
Reiterated: Buy
Price Target: $2.5
Current: $0.9358
Upside: +167.15%
Jun 29, 2026
Reiterated: Buy
Price Target: $45
Current: $26.83
Upside: +67.72%
Jun 25, 2026
Reiterated: Buy
Price Target: $8
Current: $4.54
Upside: +76.21%
Jun 23, 2026
Reiterated: Buy
Price Target: $30
Current: $14.94
Upside: +100.80%
Jun 11, 2026
Reiterated: Buy
Price Target: $4
Current: $0.65
Upside: +515.38%
May 26, 2026
Reiterated: Buy
Price Target: $23
Current: $10.50
Upside: +119.05%
May 21, 2026
Reiterated: Buy
Price Target: $4
Current: $0.3783
Upside: +957.36%
May 15, 2026
Reiterated: Buy
Price Target: $21
Current: $14.75
Upside: +42.37%
May 13, 2026
Reiterated: Buy
Price Target: $4
Current: $1.26
Upside: +217.46%
May 13, 2026
Reiterated: Buy
Price Target: $2
Current: $0.7299
Upside: +174.01%
May 11, 2026
Reiterated: Buy
Price Target: $10
Current: $5.01
Upside: +99.60%
May 8, 2026
Reiterated: Buy
Price Target: $50
Current: $19.50
Upside: +156.41%
May 7, 2026
Reiterated: Buy
Price Target: $8
Current: $4.11
Upside: +94.65%
May 7, 2026
Reiterated: Buy
Price Target: $12
Current: $5.26
Upside: +128.14%
May 6, 2026
Reiterated: Buy
Price Target: $110 → $135
Current: $101.32
Upside: +33.24%
Feb 11, 2026
Reiterated: Buy
Price Target: $100 → $120
Current: $90.86
Upside: +32.07%
Jan 23, 2026
Reiterated: Buy
Price Target: $20 → $15
Current: $7.84
Upside: +91.33%
Oct 7, 2025
Reiterated: Buy
Price Target: $6
Current: $0.6706
Upside: +794.72%
Aug 27, 2025
Reiterated: Buy
Price Target: $150
Current: $50.21
Upside: +198.75%
Aug 9, 2024
Reiterated: Buy
Price Target: $2.5
Current: $4.11
Upside: n/a
Jul 22, 2024
Reiterated: Buy
Price Target: $10
Current: $6.12
Upside: n/a
May 15, 2024
Reiterated: Buy
Price Target: $4
Current: $4.95
Upside: n/a
Nov 3, 2023
Reiterated: Buy
Price Target: $22.43 → $19.63
Current: $10.38
Upside: n/a
May 31, 2023
Reiterated: Buy
Price Target: $150 → $40
Current: $0.000001
Upside: n/a
Feb 14, 2023
Maintained: Buy
Price Target: $4 → $12
Current: $0.11
Upside: n/a
Sep 29, 2022
Maintained: Buy
Price Target: $1
Current: $2.91
Upside: n/a
May 11, 2022
Maintained: Buy
Price Target: $14 → $10
Current: $4.05
Upside: n/a
Apr 5, 2022
Initiated Coverage: Buy
Price Target: $5.61
Current: $0.30
Upside: n/a
Mar 31, 2022
Downgraded: Hold
Price Target: $6 → $10
Current: $0.0003
Upside: n/a